GP
PGEN icon

GLR Partners’s Precigen PGEN Stock Holding History

GLR Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799K Sell
140,169
-271,878
-66% -$1.18M 0.37% 53
2026
Q1 		$1.59M Buy
+412,047
New +$1.69M 0.87% 32

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GLR Partners's PGEN Position: Q2 2026 in Review

GLR Partners reduced its Precigen (PGEN) stake by 66% in Q2 2026, selling an estimated $1.18M and leaving 140,169 shares worth $799K. The position accounts for 0.37% of the portfolio, ranked #53.

GLR Partners first reported a position in PGEN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.59M in Q1 2026. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • GLR Partners held 140,169 shares of Precigen worth $799K as of Q2 2026.
  • GLR Partners sold 271,878 Precigen shares in Q2 2026, an estimated $1.18M.
  • Precigen made up 0.37% of GLR Partners's portfolio in Q2 2026, its #53 holding.
  • GLR Partners first reported a position in Precigen in Q1 2026 and has held it in 2 quarters since.
  • GLR Partners's Precigen position peaked at $1.59M in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on GLR Partners's 13F filing for Q2 2026, filed 27 Jul 2026.